Eastern Asia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Eastern Asia

The East Asian medicaments containing hormones market rose notably to $X in 2023, increasing by X% against the previous year. The total consumption indicated a strong expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. Over the period under review, the market attained the maximum level at $X in 2016; however, from 2017 to 2023, consumption stood at a somewhat lower figure.

Medicaments Containing Hormones Production in Eastern Asia

In value terms, medicaments containing hormones production expanded markedly to $X in 2023 estimated in export price. The total production indicated a strong expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth appeared the most rapid in 2015 with an increase of X%. The level of production peaked at $X in 2016; however, from 2017 to 2023, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports in Eastern Asia

Medicaments containing hormones exports reduced notably to X tons in 2023, falling by X% compared with 2022 figures. Over the period under review, exports showed a deep contraction. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The volume of export peaked at X tons in 2016; however, from 2017 to 2023, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports declined sharply to $X in 2023. In general, exports continue to indicate a mild decline. The pace of growth was the most pronounced in 2014 with an increase of X% against the previous year. Over the period under review, the exports reached the maximum at $X in 2022, and then shrank notably in the following year.

Exports by Country

South Korea represented the key exporter of medicaments containing hormones but not antibiotics in Eastern Asia, with the volume of exports resulting at X tons, which was near X% of total exports in 2023. Japan (X tons) ranks second in terms of the total exports with a X% share, followed by Hong Kong SAR (X%).

South Korea was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2023. Hong Kong SAR (X%) and Japan (X%) illustrated a downward trend over the same period. From 2012 to 2023, the share of South Korea and Hong Kong SAR increased by X and X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Japan ($X) remains the largest medicaments containing hormones supplier in Eastern Asia, comprising X% of total exports. The second position in the ranking was held by South Korea ($X), with a X% share of total exports.

From 2012 to 2023, the average annual rate of growth in terms of value in Japan totaled X%. The remaining exporting countries recorded the following average annual rates of exports growth: South Korea (X% per year) and Hong Kong SAR (X% per year).

Export Prices by Country

In 2023, the export price in Eastern Asia amounted to $X per ton, declining by X% against the previous year. In general, the export price, however, continues to indicate a strong expansion. The pace of growth appeared the most rapid in 2021 an increase of X% against the previous year. The level of export peaked at $X per ton in 2022, and then declined markedly in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Japan ($X per ton), while South Korea ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Japan (X%), while the other leaders experienced mixed trends in the export price figures.

Medicaments Containing Hormones Imports

Imports in Eastern Asia

In 2023, overseas purchases of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the second year in a row after five years of decline. Overall, imports, however, recorded a mild decrease. Over the period under review, imports reached the maximum at X tons in 2012; however, from 2013 to 2023, imports failed to regain momentum.

In value terms, medicaments containing hormones imports surged to $X in 2023. In general, imports, however, showed a perceptible descent. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. The level of import peaked at $X in 2012; however, from 2013 to 2023, imports failed to regain momentum.

Imports by Country

Japan dominates imports structure, accounting for X tons, which was approx. X% of total imports in 2023. South Korea (X tons) took a minor share of total imports.

Japan was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics imports, with a CAGR of X% from 2012 to 2023. South Korea (X%) illustrated a downward trend over the same period. While the share of Japan (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of South Korea (X p.p.) displayed negative dynamics.

In value terms, Japan ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by South Korea ($X), with a X% share of total imports.

From 2012 to 2023, the average annual growth rate of value in Japan totaled X%.

Import Prices by Country

The import price in Eastern Asia stood at $X per ton in 2023, reducing by X% against the previous year. In general, the import price saw a noticeable decrease. The pace of growth was the most pronounced in 2017 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2018 to 2023, the import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was South Korea ($X per ton), while Japan stood at $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Japan (X%).

Source: IndexBox Platform